nodes	percent_of_prediction	percent_of_DWPC	metapath
Aspartame—SLC22A11—Methotrexate—lung cancer	0.267	0.503	CbGbCtD
Aspartame—SLC22A8—Methotrexate—lung cancer	0.155	0.293	CbGbCtD
Aspartame—SLC22A6—Methotrexate—lung cancer	0.108	0.204	CbGbCtD
Aspartame—TAS1R2—Class C/3 (Metabotropic glutamate/pheromone receptors)—GRM8—lung cancer	0.044	0.0955	CbGpPWpGaD
Aspartame—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.0351	0.0761	CbGpPWpGaD
Aspartame—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.0268	0.0581	CbGpPWpGaD
Aspartame—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.0223	0.0485	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—SFN—lung cancer	0.0172	0.0372	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—FOXO3—lung cancer	0.0111	0.0242	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—GIPR—lung cancer	0.0076	0.0165	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—BRAF—lung cancer	0.00718	0.0156	CbGpPWpGaD
Aspartame—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00703	0.0153	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—MAP2K1—lung cancer	0.00676	0.0147	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—GRM8—lung cancer	0.00647	0.014	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—RAF1—lung cancer	0.00599	0.013	CbGpPWpGaD
Aspartame—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00536	0.0116	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—OXTR—lung cancer	0.00532	0.0115	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—GRP—lung cancer	0.00532	0.0115	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—CCND1—lung cancer	0.005	0.0109	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—GNG11—lung cancer	0.00498	0.0108	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00458	0.00993	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—NRAS—lung cancer	0.00451	0.00978	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—SRC—lung cancer	0.00448	0.00971	CbGpPWpGaD
Aspartame—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00448	0.00971	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—MAPK3—lung cancer	0.00432	0.00937	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—lung cancer	0.00431	0.00934	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00422	0.00915	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—PTHLH—lung cancer	0.00417	0.00903	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—ANXA1—lung cancer	0.00392	0.00849	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—GIPR—lung cancer	0.0039	0.00846	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—KRAS—lung cancer	0.00388	0.00842	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—APP—lung cancer	0.00371	0.00805	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—lung cancer	0.00371	0.00804	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00347	0.00752	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—PIK3CA—lung cancer	0.00341	0.00739	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—GRM8—lung cancer	0.00332	0.00719	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—HRAS—lung cancer	0.0033	0.00716	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00322	0.00697	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.0032	0.00693	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—lung cancer	0.00315	0.00684	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AXL—lung cancer	0.00304	0.0066	CbGpPWpGaD
Aspartame—Bortezomib—CYP1A1—lung cancer	0.00303	0.344	CrCbGaD
Aspartame—TAS1R2—GPCR ligand binding—AVP—lung cancer	0.00289	0.00626	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—AKT1—lung cancer	0.00278	0.00604	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—GRP—lung cancer	0.00273	0.00592	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—OXTR—lung cancer	0.00273	0.00592	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00268	0.00582	CbGpPWpGaD
Aspartame—TRPV1—Stimuli-sensing channels—RAF1—lung cancer	0.00263	0.00571	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—GNG11—lung cancer	0.00256	0.00555	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.00244	0.00529	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—COL4A2—lung cancer	0.00237	0.00513	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GIPR—lung cancer	0.00231	0.005	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—ADCY1—lung cancer	0.0023	0.00499	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PPP2R1B—lung cancer	0.00224	0.00486	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SDC4—lung cancer	0.00215	0.00467	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00214	0.00465	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PTHLH—lung cancer	0.00214	0.00464	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—DUSP3—lung cancer	0.00211	0.00457	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.00208	0.00451	CbGpPWpGaD
Aspartame—Amphetamine—CYP2A6—lung cancer	0.00207	0.234	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—RHEB—lung cancer	0.00207	0.00448	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.00203	0.00441	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—ANXA1—lung cancer	0.00201	0.00436	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GRM8—lung cancer	0.00196	0.00425	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—POMC—lung cancer	0.00192	0.00416	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—APP—lung cancer	0.00191	0.00413	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SKI—lung cancer	0.0019	0.00412	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—GNG11—lung cancer	0.00188	0.00409	CbGpPWpGaD
Aspartame—TRPV1—Ion channel transport—RAF1—lung cancer	0.00172	0.00373	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.00169	0.00367	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.00169	0.00367	CbGpPWpGaD
Aspartame—Lisinopril—ABCB1—lung cancer	0.00165	0.187	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—PXN—lung cancer	0.00165	0.00357	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00163	0.00354	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00162	0.00352	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GRP—lung cancer	0.00161	0.0035	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKR1C1—lung cancer	0.00161	0.0035	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—OXTR—lung cancer	0.00161	0.0035	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—TF—lung cancer	0.00157	0.00342	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GNG11—lung cancer	0.00151	0.00328	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CXCL8—lung cancer	0.00148	0.00322	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AVP—lung cancer	0.00148	0.00321	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VEGFC—lung cancer	0.00144	0.00312	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00136	0.00296	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADCY1—lung cancer	0.00136	0.00295	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SMARCA4—lung cancer	0.00132	0.00287	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PPP2R1B—lung cancer	0.00132	0.00287	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HSPB1—lung cancer	0.00128	0.00277	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTHLH—lung cancer	0.00126	0.00274	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00124	0.00269	CbGpPWpGaD
Aspartame—Enalapril—ABCB1—lung cancer	0.00121	0.137	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—ANXA1—lung cancer	0.00119	0.00258	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FLT1—lung cancer	0.00115	0.00249	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APP—lung cancer	0.00113	0.00244	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH3—lung cancer	0.00113	0.00244	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF9—lung cancer	0.00112	0.00242	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—AVP—lung cancer	0.00109	0.00237	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JUNB—lung cancer	0.00107	0.00231	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ABCB1—lung cancer	0.00106	0.00229	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CG—lung cancer	0.00103	0.00224	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00103	0.00224	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—AVP—lung cancer	0.00101	0.00218	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—POMC—lung cancer	0.000985	0.00214	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000973	0.00211	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STK11—lung cancer	0.000968	0.0021	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6R—lung cancer	0.000961	0.00208	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FOXO3—lung cancer	0.000934	0.00203	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—MAP2K1—lung cancer	0.000916	0.00199	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CD—lung cancer	0.00091	0.00197	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—GNG11—lung cancer	0.000882	0.00191	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AVP—lung cancer	0.000875	0.0019	CbGpPWpGaD
Aspartame—Nateglinide—ALB—lung cancer	0.000868	0.0982	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—IGF1R—lung cancer	0.000843	0.00183	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—APOA1—lung cancer	0.000835	0.00181	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HES1—lung cancer	0.000828	0.0018	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—RAF1—lung cancer	0.000812	0.00176	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000793	0.00172	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000793	0.00172	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CB—lung cancer	0.000793	0.00172	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—AVP—lung cancer	0.000767	0.00166	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCL8—lung cancer	0.000762	0.00165	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ERBB3—lung cancer	0.000757	0.00164	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000742	0.00161	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—TF—lung cancer	0.000737	0.0016	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL2—lung cancer	0.000728	0.00158	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TERT—lung cancer	0.000725	0.00157	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000707	0.00153	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGFR1—lung cancer	0.000704	0.00153	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HIF1A—lung cancer	0.000694	0.0015	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—GNG11—lung cancer	0.000673	0.00146	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOA1—lung cancer	0.000669	0.00145	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KDR—lung cancer	0.000663	0.00144	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ALB—lung cancer	0.000661	0.00143	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—AVP—lung cancer	0.00064	0.00139	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000619	0.00134	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APC—lung cancer	0.000611	0.00133	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KIT—lung cancer	0.000611	0.00133	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CG—lung cancer	0.000611	0.00133	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—NRAS—lung cancer	0.000611	0.00133	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—ALB—lung cancer	0.000609	0.00132	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000605	0.00131	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000605	0.00131	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EGF—lung cancer	0.000604	0.00131	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—RAF1—lung cancer	0.000598	0.0013	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—MAPK3—lung cancer	0.000585	0.00127	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—POMC—lung cancer	0.000582	0.00126	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BRAF—lung cancer	0.000574	0.00125	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6R—lung cancer	0.000568	0.00123	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CREBBP—lung cancer	0.000567	0.00123	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—TF—lung cancer	0.000562	0.00122	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—GNG11—lung cancer	0.000561	0.00122	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EGFR—lung cancer	0.000557	0.00121	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MAP2K1—lung cancer	0.000541	0.00117	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CD—lung cancer	0.000537	0.00117	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—KRAS—lung cancer	0.000526	0.00114	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—AVP—lung cancer	0.000511	0.00111	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000505	0.00109	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000505	0.00109	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000495	0.00107	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CA—lung cancer	0.000483	0.00105	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MDM2—lung cancer	0.000481	0.00104	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RAF1—lung cancer	0.00048	0.00104	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ERBB2—lung cancer	0.000475	0.00103	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—TF—lung cancer	0.000469	0.00102	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CB—lung cancer	0.000468	0.00102	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MTOR—lung cancer	0.000468	0.00102	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—ALB—lung cancer	0.000465	0.00101	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL8—lung cancer	0.00045	0.000976	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—HRAS—lung cancer	0.000447	0.00097	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CASP3—lung cancer	0.000431	0.000934	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL2—lung cancer	0.00043	0.000933	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6—lung cancer	0.000428	0.000928	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCND1—lung cancer	0.000419	0.000909	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JUN—lung cancer	0.000418	0.000907	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MMP9—lung cancer	0.000407	0.000883	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CDKN1A—lung cancer	0.000406	0.00088	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTEN—lung cancer	0.000405	0.000878	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AKT1—lung cancer	0.000395	0.000856	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—APOA1—lung cancer	0.000391	0.000848	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—AVP—lung cancer	0.00039	0.000845	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	0.000388	0.000841	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EP300—lung cancer	0.000386	0.000837	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000378	0.000819	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SRC—lung cancer	0.000375	0.000814	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VEGFA—lung cancer	0.000366	0.000793	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STAT3—lung cancer	0.000362	0.000785	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NRAS—lung cancer	0.000361	0.000783	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MAPK3—lung cancer	0.000346	0.00075	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MYC—lung cancer	0.000336	0.000729	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000331	0.000717	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EGFR—lung cancer	0.000329	0.000713	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	0.000325	0.000705	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000315	0.000683	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KRAS—lung cancer	0.000311	0.000674	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ALB—lung cancer	0.00031	0.000672	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—APOA1—lung cancer	0.000298	0.000646	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CA—lung cancer	0.000285	0.000619	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—RAF1—lung cancer	0.00028	0.000607	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TP53—lung cancer	0.000276	0.000599	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HRAS—lung cancer	0.000264	0.000573	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6—lung cancer	0.000253	0.000548	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000252	0.000547	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	0.000249	0.000539	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ALB—lung cancer	0.000236	0.000512	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKT1—lung cancer	0.000233	0.000506	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—RAF1—lung cancer	0.000214	0.000463	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000211	0.000457	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	0.000197	0.000427	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	0.000178	0.000387	CbGpPWpGaD
